WOLF Stock Overview
Operates as an animal health and wellness company in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Grey Wolf Animal Health Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.94 |
| 52 Week High | CA$1.00 |
| 52 Week Low | CA$0.60 |
| Beta | 0.43 |
| 11 Month Change | 17.50% |
| 3 Month Change | 22.08% |
| 1 Year Change | 40.30% |
| 33 Year Change | -53.00% |
| 5 Year Change | n/a |
| Change since IPO | -62.40% |
Recent News & Updates
Shareholder Returns
| WOLF | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 6.8% | -6.9% | 2.2% |
| 1Y | 40.3% | -22.8% | 23.4% |
Return vs Industry: WOLF exceeded the Canadian Pharmaceuticals industry which returned -23.2% over the past year.
Return vs Market: WOLF exceeded the Canadian Market which returned 23.4% over the past year.
Price Volatility
| WOLF volatility | |
|---|---|
| WOLF Average Weekly Movement | 11.4% |
| Pharmaceuticals Industry Average Movement | 12.0% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: WOLF has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: WOLF's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Angela Cechetto | greywolfah.com |
Grey Wolf Animal Health Corp. operates as an animal health and wellness company in Canada. It operates through two segments, the Animal Health Business Unit, and the Pharmacy Business Unit. The company engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics.
Grey Wolf Animal Health Corp. Fundamentals Summary
| WOLF fundamental statistics | |
|---|---|
| Market cap | CA$29.17m |
| Earnings (TTM) | CA$921.89k |
| Revenue (TTM) | CA$26.30m |
31.6x
P/E Ratio1.1x
P/S RatioIs WOLF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WOLF income statement (TTM) | |
|---|---|
| Revenue | CA$26.30m |
| Cost of Revenue | CA$12.83m |
| Gross Profit | CA$13.47m |
| Other Expenses | CA$12.55m |
| Earnings | CA$921.89k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.03 |
| Gross Margin | 51.21% |
| Net Profit Margin | 3.51% |
| Debt/Equity Ratio | 32.2% |
How did WOLF perform over the long term?
See historical performance and comparison